Home > Resources > Whitepapers > How IPD Can Deliver for Life Sciences

How IPD Can Deliver for Life Sciences

January 1, 2020

Life sciences is facing a number of disruptors: novel cell and gene therapies that will revolutionize manufacturing, drug delivery and pricing models; a battle for the best and brightest talent; political and public pressure on the price of medication as well as the implications of the fourth industrial revolution. These factors combine to make investment decisions more challenging. With life sciences firms placing an increasing focus on the most efficient use of capital and shorter delivery times, project delivery providers are striving to come up with leaner and more innovative strategies and solutions to meet these needs. Integrated Project Delivery (IPD) is one such strategy.

I'm For Real

Enter your details once to access all our information and resources

Spotlight

Apollo Hospitals

Driven by the vision of its Chairman, Dr. Prathap C. Reddy, the Apollo Hospitals Group pioneered corporate healthcare in India. Over the last 25 years Apollo Hospitals has become the largest integrated private hospital group in Asia with expertise in managing hospitals, clinics, health insurance, healthcare IT, Telemedicine, Education, Pharmacy retail & Medical business process outsourcing. It owns & manages over 10000 beds across 51 hospitals, 1517 pharmacies & 102 clinics & holds the distinction of being the first amongst Indian hospitals to be accredited by Joint Commission International, USA. At present five Apollo hospitals at New Delhi, Bangalore, Chennai, Hyderabad & Dhaka are accredited by JCI. The group has always pioneered introduction of the latest world class technology in India at its hospitals like 320 Slice CT, Cyber-knife, & Computer Navigated Surgery.

OTHER WHITEPAPERS
news image

Advancing drug development using in silico modeling

whitePaper | June 22, 2022

The technologic and pharmacologic advances that have enabled researchers to take aim at previously untreatable diseases have contributed to an increase in the number of molecules in the development pipeline that are challenging and difficult to manufacture.

Read More
news image

Modernizing Pharma Operations With Process Analytical Technology

whitePaper | November 18, 2022

It’s the same for manufacturers across industries and across the globe; there’s a steadily increasing pressure to meet market demand, despite facing new challenges andconstraints.

Read More
news image

Patients Diagnosed with Post-COVID Conditions

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern.

Read More
news image

A Comparison of Substance Use Disorders before and during theCOVID-19 Pandemic

whitePaper | September 22, 2022

During the COVID-19 pandemic, drug overdose deaths have increased. At the same time, access to and utilization of substance use disorder treatment services have decreased.

Read More
news image

Infosys and Top Pharma Bring Digital Transformation to DrugManufacturing Data

whitePaper | April 1, 2022

In 2017, a top 20 global pharmaceutical company began a journey to digitally transform its pharmaceutical engineering and manufacturing capabilities by constructing a data integration and visualization platform, with strategic assistance and technical implementation provided by its partner Infosys.

Read More
news image

Considerations for migrating a drug product presentation from vial to pre-filled syringe

whitePaper | December 9, 2022

There is an upward trend for pharmaceutical companies to ask their contract development and manufacturing organisations (CDMO) to support the conversion.

Read More

Advancing drug development using in silico modeling

whitePaper | June 22, 2022

The technologic and pharmacologic advances that have enabled researchers to take aim at previously untreatable diseases have contributed to an increase in the number of molecules in the development pipeline that are challenging and difficult to manufacture.

Read More

Modernizing Pharma Operations With Process Analytical Technology

whitePaper | November 18, 2022

It’s the same for manufacturers across industries and across the globe; there’s a steadily increasing pressure to meet market demand, despite facing new challenges andconstraints.

Read More

Patients Diagnosed with Post-COVID Conditions

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern.

Read More

A Comparison of Substance Use Disorders before and during theCOVID-19 Pandemic

whitePaper | September 22, 2022

During the COVID-19 pandemic, drug overdose deaths have increased. At the same time, access to and utilization of substance use disorder treatment services have decreased.

Read More

Infosys and Top Pharma Bring Digital Transformation to DrugManufacturing Data

whitePaper | April 1, 2022

In 2017, a top 20 global pharmaceutical company began a journey to digitally transform its pharmaceutical engineering and manufacturing capabilities by constructing a data integration and visualization platform, with strategic assistance and technical implementation provided by its partner
Infosys.

Read More

Considerations for migrating a drug product presentation from vial to pre-filled syringe

whitePaper | December 9, 2022

There is an upward trend for pharmaceutical companies to ask their contract development and manufacturing organisations (CDMO) to support the conversion.

Read More
More Whitepapers

Spotlight

Apollo Hospitals

Driven by the vision of its Chairman, Dr. Prathap C. Reddy, the Apollo Hospitals Group pioneered corporate healthcare in India. Over the last 25 years Apollo Hospitals has become the largest integrated private hospital group in Asia with expertise in managing hospitals, clinics, health insurance, healthcare IT, Telemedicine, Education, Pharmacy retail & Medical business process outsourcing. It owns & manages over 10000 beds across 51 hospitals, 1517 pharmacies & 102 clinics & holds the distinction of being the first amongst Indian hospitals to be accredited by Joint Commission International, USA. At present five Apollo hospitals at New Delhi, Bangalore, Chennai, Hyderabad & Dhaka are accredited by JCI. The group has always pioneered introduction of the latest world class technology in India at its hospitals like 320 Slice CT, Cyber-knife, & Computer Navigated Surgery.

Events